Pulmonary embolism after transcatheter arterial chemoembolization

Abstract

Metastatic hepatic tumours can be treated with hepatic transcatheter arterial chemoembolization (TACE). Common complications associated with TACE include hepatic insufficiency, fever, and pain. However, pulmonary embolism is rarely documented as a fatal adverse effect. We report a case of pulmonary embolism following TACE in a renal cell carcinoma patient with liver metastases. Total recovery is noted after the effective treatment.

Development of thermosensitive chitosan/glicerophospate injectablein situgelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study

“…High viscosity may help to control injection, to avoid dilution of the solution and to limit the possibility of migration into collateral arteries [31]. In the latter case, if the arterial blood flow disperses the embolic agent, cardiopulmonary embolism may occur [38][39][40][41][42]. However, too fast gelation may be problematic because it could determine catheter occlusion.…”

Pulmonary Lipiodol Embolism after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

“…Anecdotal success has been achieved with treatments including oxygenation, high-dose methylprednisolone, heparin, and positive end-expiratory pressure (PEEP). 9 In this patient, his oxygenation responded dramatically after using a protective ventilatory strategy, methylprednisolone, and LMWH. Corticosteroids can limit local accumulation of free fatty acids, inhibit complement-mediated leukocyte aggregation, and block further cytokine storm.…”